Morbus Crohn der DGVS

1134
Leitlinie
58 Potthast S, Rieber A, Von Tirpitz C et al. Ultrasound and magnetic resonance
imaging in Crohn’s disease: a comparison. Eur Radiol 2002;
12: 1416–1422
59 Ludwig D, Wiener S, Bruning A et al. Mesenteric blood flow is related
to disease activity and risk of relapse in Crohn’s disease: a prospective
follow-up study. Am J Gastroenterol 1999; 94: 2942–2950
60 Homann N, Klarmann U, Fellermann K et al. Mesenteric pulsatility index
analysis predicts response to azathioprine in patients with
Crohn’s disease. Inflamm Bowel Dis 2005; 11: 126–132
61 Heyne R, Rickes S, Bock P et al. Non-invasive evaluation of activity in
inflammatory bowel disease by power Doppler sonography. Z Gastroenterol
2002; 40: 171–175
62 Di Sabatino A, Fulle I, Ciccocioppo R et al. Doppler enhancement after
intravenous levovist injection in Crohn’s disease. Inflamm Bowel Dis
2002; 8: 251–257
63 Wagtmans MJ, Verspaget HW, Lamers CB et al. Clinical aspects of
Crohn’s disease of the upper gastrointestinal tract: a comparison
with distal Crohn’s disease. Am J Gastroenterol 1997; 92: 1467–1471
64 Rutgeerts P, Onette E, Vantrappen G et al. Crohn’s disease of the stomach
and duodenum: A clinical study with emphasis on the value of
endoscopy and endoscopic biopsies. Endoscopy 1980; 12: 288–294
65 Albert JG, Martiny F, Krummenerl A et al. Diagnosis of small bowel
Crohn’s disease: a prospective comparison of capsule endoscopy
with magnetic resonance imaging and fluoroscopic enteroclysis.
Gut 2005; 54: 1721–1727
66 Golder SK, Schreyer AG, Endlicher E et al. Comparison of capsule endoscopy
and magnetic resonance (MR) enteroclysis in suspected
small bowel disease. Int J Colorectal Dis 2006; 21: 97–104
67 Voderholzer WA, Beinhoelzl J, Rogalla P et al. Small bowel involvement
in Crohn’s disease: a prospective comparison of wireless capsule
endoscopy and computed tomography enteroclysis. Gut 2005;
54: 369–373
68 Liangpunsakul S, Chadalawada V, Rex DK et al. Wireless capsule endoscopy
detects small bowel ulcers in patients with normal results
from state of the art enteroclysis. Am J Gastroenterol 2003; 98:
1295–1298
69 Eliakim R, Fischer D, Suissa A et al. Wireless capsule video endoscopy
is a superior diagnostic tool in comparison to barium follow-through
and computerized tomography in patients with suspected Crohn’s
disease. Eur J Gastroenterol Hepatol 2003; 15: 363–367
70 Triester SL, Leighton JA, Leontiadis GI et al. A meta-analysis of the yield
of capsule endoscopy compared to other diagnostic modalities in patients
with non-stricturing small bowel Crohn’s disease. Am J Gastroenterol
2006; 101: 954–964
71 Graham DY, Opekun AR, Willingham FF et al. Visible small-intestinal
mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol
2005; 3: 55–59
72 Goldstein JL, Eisen GM, Lewis B et al. Video capsule endoscopy to prospectively
assess small bowel injury with celecoxib, naproxen plus
omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3:
133–141
73 Oshitani N, Yukawa T, Yamagami H et al. Evaluation of deep small bowel
involvement by double-balloon enteroscopy in Crohn’s disease.
Am J Gastroenterol 2006; 101: 1484–1489
74 Geerling BJ, Badart-Smook A, Stockbrugger RW et al. Comprehensive
nutritional status in recently diagnosed patients with inflammatory
bowel disease compared with population controls. Eur J Clin Nutr
2000; 54: 514–521
75 Filippi J, Al-Jaouni R, Wiroth JB et al. Nutritional deficiencies in patients
with Crohn’s disease in remission. Inflamm Bowel Dis 2006;
12: 185–191
76 Rodemann JF, Dubberke ER, Reske KA et al. Incidence of Clostridium
difficile infection in inflammatory bowel disease. Clin Gastroenterol
Hepatol 2007; 5: 339–344
77 Issa M, Vijayapal A, Graham MB et al. Impact of Clostridium difficile
on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5:
345–351
78 Takahashi Y, Tange T. Prevalence of cytomegalovirus infection in inflammatory
bowel disease patients. Dis Colon Rectum 2004; 47:
722–726
79 Dimitroulia E, Spanakis N, Konstantinidou AE et al. Frequent detection
of cytomegalovirus in the intestine of patients with inflammatory
bowel disease. Inflamm Bowel Dis 2006; 12: 879–884
80 Cottone M, Pietrosi G, Martorana G et al. Prevalence of cytomegalovirus
infection in severe refractory ulcerative and Crohn’s colitis. Am J
Gastroenterol 2001; 96: 773–775
81 Hommes DW, Sterringa G, van Deventer SJ et al. The pathogenicity of
cytomegalovirus in inflammatory bowel disease: a systematic review
and evidence-based recommendations for future research. Inflamm
Bowel Dis 2004; 10: 245–250
82 Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative
colitis: a meta-analysis. Gut 2001; 48: 526–535
83 Jess T, Gamborg M, Matzen P et al. Increased risk of intestinal cancer
in Crohn’s disease: a meta-analysis of population-based cohort studies.
Am J Gastroenterol 2005; 100: 2724–2729
84 Jess T, Loftus Jr EV, Velayos FS et al. Risk of intestinal cancer in inflammatory
bowel disease: a population-based study from olmsted
county, Minnesota. Gastroenterology 2006; 130: 1039–1046
85 Bernstein CN, Blanchard JF, Kliewer E et al. Cancer risk in patients with
inflammatory bowel disease: a population-based study. Cancer
2001; 91: 854–862
86 Hoffmann JC, Zeitz M, Bischoff SC et al. Diagnosis and therapy of ulcerative
colitis: results of an evidence based consensus conference by
the German society of Digestive and Metabolic Diseases and the
competence network on inflammatory bowel disease. Z Gastroenterol
2004; 42: 979–983
87 Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2
associated with susceptibility to Crohn’s disease. Nature 2001; 411:
603–606
88 Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucinerich
repeat variants with susceptibility to Crohn’s disease. Nature
2001; 411: 599–603
89 Ahmad T, Armuzzi A, Bunce M et al. The molecular classification of the
clinical manifestations of Crohn’s disease. Gastroenterology 2002;
122: 854–866
90 Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis
and genotype-phenotype correlation in 612 patients with inflammatory
bowel disease. Am J Hum Genet 2002; 70: 845–857
91 Radlmayr M, Torok HP, Martin K et al. The c-insertion mutation of the
NOD2 gene is associated with fistulizing and fibrostenotic phenotypes
in Crohn’s disease. Gastroenterology 2002; 122: 2091–2092
92 Peeters M, Joossens S, Vermeire S et al. Diagnostic value of anti-
Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies
in inflammatory bowel disease. Am J Gastroenterol 2001; 96:
730–734
93 Zholudev A, Zurakowski D, Young W et al. Serologic testing with AN-
CA, ASCA, and anti-OmpC in children and young adults with Crohn’s
disease and ulcerative colitis: diagnostic value and correlation with
disease phenotype. Am J Gastroenterol 2004; 99: 2235–2241
94 Plevy S. Do serological markers and cytokines determine the indeterminate?
J Clin Gastroenterol 2004; 38: S51–56
95 Hollander D, Vadheim CM, Brettholz E et al. Increased intestinal permeability
in patients with Crohn’s disease and their relatives. A possible
etiologic factor. Ann Intern Med 1986; 105: 883–885
96 Wyatt J, Vogelsang H, Hubl W et al. Intestinal permeability and the
prediction of relapse in Crohn’s disease. Lancet 1993; 341:
1437–1439
97 Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical,
molecular and serological classification of inflammatory bowel
disease: Report of a Working Party of the 2005 Montreal World Congress
of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A):
5–36
98 Allison MC, Hamilton-Dutoit SJ, Dhillon AP et al. The value of rectal
biopsy in distinguishing self-limited colitis from early inflammatory
bowel disease. Q J Med 1987; 65: 985–995
99 Bentley E, Jenkins D, Campbell F et al. How could pathologists improve
the initial diagnosis of colitis? Evidence from an international workshop.
J Clin Pathol 2002; 55: 955–960
100 Dejaco C, Oesterreicher C, Angelberger S et al. Diagnosing colitis: a
prospective study on essential parameters for reaching a diagnosis.
Endoscopy 2003; 35: 1004–1008
101 Dube AK, Cross SS, Lobo AJ. Audit of the histopathological diagnosis of
non-neoplastic colorectal biopsies: achievable standards for the diagnosis
of inflammatory bowel disease. J Clin Pathol 1998; 51:
378–381
102 Dundas SA, Dutton J, Skipworth P. Reliability of rectal biopsy in distinguishing
between chronic inflammatory bowel disease and acute
self-limiting colitis. Histopathology 1997; 31: 60–66
Hoffmann JC et al. Diagnostik und Therapie… Z Gastroenterol 2008; 46: 1094–1146